So we are on track for an announcement in late May early June.I think it will be late May so that Dr Ketelbey can attend the Boston conference armed with the results.
Would like to hear your predictions of the share price..
My thoughts........
1) Negative results.Highly unlikely so I will ignore that possibility.
2) DSMB analysis shows no safety issues and the trial proceeds. Share price 6 to 8c
3) DSMB analysis shows no safety issues and positive results in some patients Share price rockets to 20 to 50c
This will be followed by a partnership with Pfizer which will fire the boosters on our rocket.
It must be the combination of diazepam and red wine which is making me hallucinate.
Ann: XanADu Interim Analysis on track for May/June, page-3
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.5¢ |
Change
-0.001(3.85%) |
Mkt cap ! $77.06M | |||
| Open | High | Low | Value | Volume |
| 2.7¢ | 2.7¢ | 2.5¢ | $83.82K | 3.202M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 1220105 | 2.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.6¢ | 768793 | 4 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| ACW (ASX) Chart |